These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 34369258)

  • 41. TMEM25 is a candidate biomarker methylated and down-regulated in colorectal cancer.
    Hrašovec S; Hauptman N; Glavač D; Jelenc F; Ravnik-Glavač M
    Dis Markers; 2013; 34(2):93-104. PubMed ID: 23324576
    [TBL] [Abstract][Full Text] [Related]  

  • 42. NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer.
    Liu M; Peng Y; Wang X; Guo Q; Shen S; Li G
    BMC Cancer; 2010 Apr; 10():160. PubMed ID: 20423473
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Methylation analysis of Gasdermin E shows great promise as a biomarker for colorectal cancer.
    Ibrahim J; Op de Beeck K; Fransen E; Croes L; Beyens M; Suls A; Vanden Berghe W; Peeters M; Van Camp G
    Cancer Med; 2019 May; 8(5):2133-2145. PubMed ID: 30993897
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
    Mossman D; Kim KT; Scott RJ
    BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of catechol-O-methyltransferase gene variants on methylation status of P16 and MGMT genes and their downregulation in colorectal cancer.
    Wani HA; Majid S; Bhat AA; Amin S; Farooq R; Bhat SA; Naikoo NA; Beigh MA; Kadla SA
    Eur J Cancer Prev; 2019 Mar; 28(2):68-75. PubMed ID: 30379684
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Promoter hypermethylation of GALR1 acts as an early epigenetic susceptibility event in colorectal carcinogenesis.
    Gu S; Qian S; Lin S; Ye D; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Chen K; Jin M
    J Hum Genet; 2022 Sep; 67(9):519-525. PubMed ID: 35606503
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of GABRA1 and LAMA2 as new DNA methylation markers in colorectal cancer.
    Lee S; Oh T; Chung H; Rha S; Kim C; Moon Y; Hoehn BD; Jeong D; Lee S; Kim N; Park C; Yoo M; An S
    Int J Oncol; 2012 Mar; 40(3):889-98. PubMed ID: 22038115
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypermethylated MAL gene - a silent marker of early colon tumorigenesis.
    Lind GE; Ahlquist T; Kolberg M; Berg M; Eknaes M; Alonso MA; Kallioniemi A; Meling GI; Skotheim RI; Rognum TO; Thiis-Evensen E; Lothe RA
    J Transl Med; 2008 Mar; 6():13. PubMed ID: 18346269
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypermethylation of CpG island in O6-methylguanine-DNA methyltransferase gene was associated with K-ras G to A mutation in colorectal tumor.
    Qi J; Zhu YQ; Huang MF; Yang D
    World J Gastroenterol; 2005 Apr; 11(13):2022-5. PubMed ID: 15800999
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mapping of DNA Hypermethylation and Hypomethylation induced by Folate Deficiency in Sporadic Colorectal Cancer and Clinical Implication Analysis of Hypermethylation Pattern in CBS Promoter.
    Zhang Z; He Y; Tu X; Huang S; Chen Z; Wang L; Song J
    Clin Lab; 2017 Apr; 63(4):733-748. PubMed ID: 28397458
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypermethylation of ITGA4, TFPI2 and VIMENTIN promoters is increased in inflamed colon tissue: putative risk markers for colitis-associated cancer.
    Gerecke C; Scholtka B; Löwenstein Y; Fait I; Gottschalk U; Rogoll D; Melcher R; Kleuser B
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2097-107. PubMed ID: 25902909
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Integrated Analysis of the Endoscopic, Pathological and Molecular Characteristics of Colorectal Tumorigenesis.
    Suzuki H; Yamamoto E; Yamano HO; Nakase H; Sugai T
    Digestion; 2019; 99(1):33-38. PubMed ID: 30554192
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DNA methylation markers in colorectal cancer.
    Kim MS; Lee J; Sidransky D
    Cancer Metastasis Rev; 2010 Mar; 29(1):181-206. PubMed ID: 20135198
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Altered regulation of DNA ligase IV activity by aberrant promoter DNA methylation and gene amplification in colorectal cancer.
    Kuhmann C; Li C; Kloor M; Salou M; Weigel C; Schmidt CR; Ng LW; Tsui WW; Leung SY; Yuen ST; Becker N; Weichenhan D; Plass C; Schmezer P; Chan TL; Popanda O
    Hum Mol Genet; 2014 Apr; 23(8):2043-54. PubMed ID: 24282031
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association between folate levels and CpG Island hypermethylation in normal colorectal mucosa.
    Wallace K; Grau MV; Levine AJ; Shen L; Hamdan R; Chen X; Gui J; Haile RW; Barry EL; Ahnen D; McKeown-Eyssen G; Baron JA; Issa JP
    Cancer Prev Res (Phila); 2010 Dec; 3(12):1552-64. PubMed ID: 21149331
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sensitive and Noninvasive Detection of Aberrant SFRP2 and MGMT-B Methylation in Iranian Patients with Colon Polyps.
    Naini MA; Mokarram P; Kavousipour S; Zare N; Atapour A; Zarin1 MH; Mehrabani G; Borji M
    Asian Pac J Cancer Prev; 2016; 17(4):2185-93. PubMed ID: 27221916
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gene promoter and exon DNA methylation changes in colon cancer development - mRNA expression and tumor mutation alterations.
    Molnár B; Galamb O; Péterfia B; Wichmann B; Csabai I; Bodor A; Kalmár A; Szigeti KA; Barták BK; Nagy ZB; Valcz G; Patai ÁV; Igaz P; Tulassay Z
    BMC Cancer; 2018 Jun; 18(1):695. PubMed ID: 29945573
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Screening for genomic fragments that are methylated specifically in colorectal carcinoma with a methylated MLH1 promoter.
    Koinuma K; Kaneda R; Toyota M; Yamashita Y; Takada S; Choi YL; Wada T; Okada M; Konishi F; Nagai H; Mano H
    Carcinogenesis; 2005 Dec; 26(12):2078-85. PubMed ID: 16033773
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer.
    Kawakami K; Ruszkiewicz A; Bennett G; Moore J; Grieu F; Watanabe G; Iacopetta B
    Br J Cancer; 2006 Feb; 94(4):593-8. PubMed ID: 16421593
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of DNA from human stools to detect aberrant CpG island methylation of genes implicated in colorectal cancer.
    Belshaw NJ; Elliott GO; Williams EA; Bradburn DM; Mills SJ; Mathers JC; Johnson IT
    Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1495-501. PubMed ID: 15342451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.